Tirzepatide is a dual-acting prescription medication that mimics the GIP and GLP-1 hormones to stimulate insulin release, slow stomach emptying, and suppress appetite. Administered via weekly subcutaneous injection, it is FDA-approved for treating Type 2 diabetes, chronic weight management, and obstructive sleep apnea.